Literature DB >> 3524023

Complications of cyclosporin therapy.

B D Kahan, S M Flechner, M I Lorber, C Jensen, D Golden, C T Van Buren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3524023     DOI： 10.1007/bf01655294

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  65 in total

Review 1.  Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters.

Authors:  B D Kahan
Journal:  Transplantation       Date:  1985-11       Impact factor: 4.939

2.  Cyclosporin interaction with ketoconazole and melphalan.

Authors:  G R Morgenstern; R Powles; B Robinson; T J McElwain
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

3.  Cyclosporin A tissue levels in a cadaveric renal allograft recipient.

Authors:  B D Kahan; C T Van Buren; M Boileau; M Ried; W D Payne; S Flechner; J Newburger
Journal:  Transplantation       Date:  1983-01       Impact factor: 4.939

4.  The value of serial serum trough cyclosporine levels in human renal transplantation.

Authors:  B D Kahan; C A Wideman; M Reid; S Gibbons; M Jarowenko; S Flechner; C T Van Buren
Journal:  Transplant Proc       Date:  1984-10       Impact factor: 1.066

5.  Nephrotoxicity of cyclosporin A in liver and kidney transplant patients.

Authors:  G B Klintmalm; S Iwatsuki; T E Starzl
Journal:  Lancet       Date:  1981-02-28       Impact factor: 79.321

6.  Experimental cyclosporin A nephrotoxicity.

Authors:  P H Whiting; A W Thomson; J T Blair; J G Simpson
Journal:  Br J Exp Pathol       Date:  1982-02

7.  Cyclosporin-A deposits in renal allografts.

Authors:  E von Willebrand; P Häyry
Journal:  Lancet       Date:  1983-07-23       Impact factor: 79.321

8.  Cyclosporin A-induced increases in renin storage and release.

Authors:  C R Baxter; G G Duggin; N S Willis; B M Hall; J S Horvath; D J Tiller
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1982-08

9.  Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury.

Authors:  H Shulman; G Striker; H J Deeg; M Kennedy; R Storb; E D Thomas
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245

10.  Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR.

Authors:  H Helin; T S Edgington
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307
View more
  7 in total

Review 1.  Recent developments in dialysis and transplantation.

Authors:  D B Gradus; R N Fine
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

2.  Graft survival and long-term renal function after sequential conventional cyclosporin A therapy in cadaver kidney transplantation--a prospective randomized trial.

Authors:  R Grundmann; U Hesse; P Wienand; C Baldamus; W Arns
Journal:  Klin Wochenschr       Date:  1987-09-15

3.  Cyclosporine induces abnormal facial bone growth in children: a preliminary study.

Authors:  V M Reznik; J S Berger; K L Jones; S A Mendoza
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

4.  Chronic administration of cyclosporin A induces a decrease in hepatic excretory function in man.

Authors:  J F Cadranel; S Erlinger; M Desruenne; J Luciani; F Lunel; P Grippon; A Cabrol; P Opolon
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

Review 5.  Liver transplantation: current concepts.

Authors:  W J Wall
Journal:  CMAJ       Date:  1988-07-01       Impact factor: 8.262

6.  Effect of chronic administration of cyclosporin A on hepatic uptake and biliary secretion of bromosulfophthalein in rat.

Authors:  J F Cadranel; M Dumont; V A Mesa; C Degott; D Touchard; S Erlinger
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

7.  Molecular basis for the immunosuppressive action of stearic acid on T cells.

Authors:  P W Tebbey; T M Buttke
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.